FindTrial
Sign In

Pain killer role of ketoprofen patch to decrease needle prick pain

Double blind randomized control trial to evaluate the efficacy of ketoprofen patch to attenuate pain during venous cannulation - DREKPV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007694
Enrollment
200
Registered
2017-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z418- Encounter for other procedures forpurposes other than remedying health state Health Condition 2: null- healthy

Interventions

Intervention1: Group II(Ketoprofen patch ): received a ketoprofen patch on dorsum of non-dominant hand of patients, 1 hour prior to intravenous cannulation Control Intervention1: Group II ( EMLA ): r

Sponsors

Sanjay Gandhi Postgraduate Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I or II, scheduled for elective gastrointestinal surgeries are enrolled for the study

Exclusion criteria

Exclusion criteria: history of analgesic consumption, drug abuse, skin allergy, atopy, ketoprofen allergy and local anaesthestic allergy

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of ketoprofen patch for attenuating pain during venous cannulationTimepoint: pain assessment was donejust after intravenous cannulation and before induction of anaesthesia—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactSanjay Kumar

Sanjay Gandhi Post Graduate Institute of Medical Sciences

drsanjaygupta9@gmail.com05222665528

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026